Monday, October 5, 2026

Meta Cuts 10% of Reality Labs, Shuts Down Multiple VR Gaming Studios

Meta cuts 10% of Reality Labs, closing VR gaming studios like Twisted Pixel and Sanzaru, signaling a shift in metaverse investments.

LM Salvado

January 15, 2026

Meta Cuts 10% of Reality Labs, Shuts Down Multiple VR Gaming Studios
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Meta is cutting about 10 percent of its Reality Labs metaverse division, including shutting down several virtual reality (VR) gaming studios, according to The Verge AI. This move signals a significant shift in Meta’s strategic investments in the metaverse, a term used to describe immersive digital environments where users can interact virtually.

The closures affect Twisted Pixel Games, known for developing Marvel’s Deadpool VR, and Sanzaru Games, the creator of the Asgard’s Wrath series. Additionally, Armature Studio, responsible for the Resident Evil 4 VR port, will also cease operations. These studio closures represent a substantial setback for Meta’s ambitions in the VR gaming space, which once included high-profile acquisitions of these studios in recent years.

According to The Verge AI, Meta spokesperson Tracy Clayton confirmed that the team behind the VR fitness app Supernatural will no longer develop new content or features for it, although existing support will continue. The closures have left many developers without jobs, as evidenced by posts on social media platforms. Former Twisted Pixel level designer Andy Gentile shared, “It appears the entire Twisted Pixel Games studio has been shut down along with Sanzaru and Armature too.”

This downsizing follows Meta’s previous closure of Echo VR developer Ready at Dawn in 2024, another studio acquired in 2020. In a statement about the broader Reality Labs layoffs, Clayton noted that the company was “shifting some of our investment focus.” The future direction of Meta’s metaverse efforts remains uncertain, but the recent layoffs suggest a period of reassessment and realignment for the tech giant.

Despite the current retrenchment, Meta’s long-term commitment to the metaverse is still expected to continue, albeit with a more streamlined approach. The exact implications for Meta’s future projects in the space remain to be seen.

As the tech industry continues to navigate economic challenges and evolving consumer preferences, Meta’s decision underscores the competitive and volatile nature of the metaverse sector. The outlook for Meta’s metaverse initiatives suggests a period of consolidation and reevaluation.

In the wake of these layoffs, the VR gaming community is grappling with the impact of these changes, while also keeping an eye on how Meta will proceed with its remaining projects and investments in the metaverse. The broader industry will likely watch closely to see if other major players follow suit in scaling back their metaverse ambitions.

This restructuring comes as Meta faces increased scrutiny and pressure to demonstrate the commercial viability of its metaverse projects. The company’s recent moves indicate a recalibration of its approach to ensure sustainability and alignment with market demands.

The future of VR gaming and the metaverse at large remains uncertain, but Meta’s actions signal a pivotal moment in the development of immersive technologies. The company’s next steps will be closely monitored by both industry insiders and consumers alike.

While the immediate impact is a reduction in workforce and operational scope, the long-term effects on Meta’s metaverse strategy and the broader industry remain to be seen. The outlook for Meta’s future projects in the metaverse is one of cautious optimism amid ongoing adjustments.

This restructuring highlights the evolving landscape of the metaverse, with companies like Meta navigating the challenges of creating sustainable, engaging virtual environments. The future direction of Meta’s metaverse efforts will depend on how effectively it can adapt to changing market conditions and technological advancements.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s metaverse projects remains uncertain, with the company’s next steps crucial in determining the future of immersive technologies.

The outlook for Meta’s met

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com